LGALS3 and stroke disorder: Based on these possible mechanisms of Gal-3 as a biomarker for prognosis in stroke patients and the evidence from animal trial studies, this review focused on the influence of Gal-3 on stroke functional outcomes indicated by mRS and mortality outcome.